Y. X. Ding

512 total citations
20 papers, 374 citations indexed

About

Y. X. Ding is a scholar working on Pathology and Forensic Medicine, Oncology and Ophthalmology. According to data from OpenAlex, Y. X. Ding has authored 20 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 7 papers in Ophthalmology. Recurrent topics in Y. X. Ding's work include Viral-associated cancers and disorders (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Glaucoma and retinal disorders (4 papers). Y. X. Ding is often cited by papers focused on Viral-associated cancers and disorders (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Glaucoma and retinal disorders (4 papers). Y. X. Ding collaborates with scholars based in China, South Korea and United States. Y. X. Ding's co-authors include Chun‐Kui Shao, Hong Du, Haigang Li, Jianning Chen, Huijing Ye, Huasheng Yang, Ye Jiang, Jing Han, Zhiying Feng and Qian Li and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Y. X. Ding

19 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. X. Ding China 10 183 130 88 83 66 20 374
Bradley A. Thuro United States 13 258 1.4× 195 1.5× 119 1.4× 41 0.5× 146 2.2× 22 532
Ravneet Bajwa United States 8 182 1.0× 55 0.4× 107 1.2× 37 0.4× 29 0.4× 26 368
Yufang Zhu China 13 89 0.5× 41 0.3× 162 1.8× 31 0.4× 17 0.3× 41 518
Siming Ai China 11 44 0.2× 37 0.3× 67 0.8× 31 0.4× 61 0.9× 25 225
Francesca Leonardi Italy 10 111 0.6× 169 1.3× 72 0.8× 31 0.4× 105 1.6× 17 443
Mami Nakahara Japan 12 86 0.5× 58 0.4× 87 1.0× 31 0.4× 11 0.2× 14 375
Arvind Sabesan United States 8 191 1.0× 73 0.6× 86 1.0× 88 1.1× 147 2.2× 16 431
Rosemary Kane Ireland 10 33 0.2× 27 0.2× 208 2.4× 27 0.3× 114 1.7× 16 447
Ken Takeshima Japan 14 168 0.9× 32 0.2× 56 0.6× 86 1.0× 6 0.1× 34 476
Irene Low New Zealand 9 96 0.5× 37 0.3× 106 1.2× 32 0.4× 5 0.1× 14 360

Countries citing papers authored by Y. X. Ding

Since Specialization
Citations

This map shows the geographic impact of Y. X. Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. X. Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. X. Ding more than expected).

Fields of papers citing papers by Y. X. Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. X. Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. X. Ding. The network helps show where Y. X. Ding may publish in the future.

Co-authorship network of co-authors of Y. X. Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Y. X. Ding. A scholar is included among the top collaborators of Y. X. Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. X. Ding. Y. X. Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qian, Ningyu An, Cheng Liu, et al.. (2024). Single-cell BCR and transcriptome analysis reveals peripheral immune signatures in patients with thyroid-associated ophthalmopathy. Aging. 16(9). 8217–8245. 4 indexed citations
2.
Zhang, Yaxing, Jing Wang, Y. X. Ding, et al.. (2020). Migrasome and Tetraspanins in Vascular Homeostasis: Concept, Present, and Future. Frontiers in Cell and Developmental Biology. 8. 438–438. 44 indexed citations
3.
Guo, Chen, Y. X. Ding, Qian Li, et al.. (2019). Defective Regulatory B Cells Are Associated With Thyroid-Associated Ophthalmopathy. The Journal of Clinical Endocrinology & Metabolism. 104(9). 4067–4077. 16 indexed citations
4.
Ding, Y. X., Chen Guo, Qian Li, et al.. (2018). Frequency of IL-10-producing regulatory B cells associated with disease activity in thyroid-associated orbitopathy. International Journal of Ophthalmology. 11(9). 1458–1462. 6 indexed citations
5.
Li, Qian, Huijing Ye, Y. X. Ding, et al.. (2017). Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases. PLoS ONE. 12(5). e0176064–e0176064. 44 indexed citations
6.
Ye, Huijing, Yi Du, Rongxin Chen, et al.. (2016). The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma. Current Eye Research. 41(11). 1507–1512. 3 indexed citations
7.
Chen, Rongxin, Shu Liu, Huijing Ye, et al.. (2015). Association of p53 rs1042522, MDM2 rs2279744 and p21 rs1801270 polymorphisms with retinoblastoma risk and invasion in a Chinese population. Scientific Reports. 5(1). 13300–13300. 24 indexed citations
8.
Ye, Huijing, et al.. (2015). Clinical characteristics and prognosis of patients with retinoblastoma: 8-year follow-up. TURKISH JOURNAL OF MEDICAL SCIENCES. 45(6). 1256–1262. 5 indexed citations
10.
Xu, Xiaoyu, Yi Du, Y. X. Ding, Huijing Ye, & Huasheng Yang. (2013). Idiopathic orbital inflammation associated with panuveitis in an adult and a review of the literature.. PubMed. 28(1). 40–3. 3 indexed citations
11.
Han, Jing, Jianning Chen, Zhigang Zhang, et al.. (2012). Sequence Variations of Latent Membrane Protein 2A in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China. PLoS ONE. 7(3). e34276–e34276. 11 indexed citations
12.
Chen, Jianning, Nana Zhang, Ye Jiang, et al.. (2012). Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China. PLoS ONE. 7(11). e50084–e50084. 11 indexed citations
13.
Liang, Xiaoling, Huanjiao Jenny Zhou, Y. X. Ding, et al.. (2012). TMP Prevents Retinal Neovascularization and Imparts Neuroprotection in an Oxygen-Induced Retinopathy Model. Investigative Ophthalmology & Visual Science. 53(4). 2157–2157. 45 indexed citations
14.
16.
Han, Jing, Dan He, Zhiying Feng, Y. X. Ding, & Chun‐Kui Shao. (2010). [Clinicopathologic features and protein expression study of Epstein-Barr virus-associated gastric carcinoma in Guangzhou].. PubMed. 39(12). 798–803. 5 indexed citations
17.
Zhang, Wenxin, Y. X. Ding, & Yongping Li. (2010). [Pathology analysis of CD31,CD34 and vWF expression in vascular endothelial cell of granulation tissue of eyelid chalazion].. PubMed. 25(1). 52–6. 1 indexed citations
18.
Chen, Jianning, Y. X. Ding, Zhiying Feng, et al.. (2010). Association of distinctive Epstein–Barr virus variants with gastric carcinoma in Guangzhou, southern China. Journal of Medical Virology. 82(4). 658–667. 58 indexed citations
19.
Zhou, Huanjiao Jenny, et al.. (2010). [An improved method of culturing human umbilical vein endothelial cells and its characterization].. PubMed. 25(2). 99–102. 1 indexed citations
20.
Yuan, Cai, et al.. (1990). Regioselective Phosphorylation of Ambident Anions and Electrophilic Reaction of Carbanion of Allyl-Phosphonate. Phosphorus, sulfur, and silicon and the related elements. 51(1-4). 301–301.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026